- 4357
- 259
- 3
- 1
- 0
- Help Ukraine
About the solution
Anthony is a medical researcher and bio-hacker. He and his team are working on a protocol to extract insulin from genetically engineered yeast cells and produce a generic drug at a cost of around $10 for a month's supply. According to the bio-hacker, the users could eventually be able to produce the drug in their homes.
“The state of the art in diabetes treatment has changed little in decades, something that I personally am frustrated by along with many others living with diabetes. Whether directly or indirectly, we’re hoping our work will improve access to insulin.”
The idea to create insulin stroke the medical researcher after he co-founded, in 2011, Counter Culture Labs, a biohackerspace. In 2015, Anthony met Isaac Yonemoto, who has a background working on insulin, and Arcturus BioCloud, a biotech startup that could provide DNA synthesis services.
A team was starting to be formed and then they launched a crowdfunding campaign to help them conduct their experiments, which started in 2016.
So far the group was able to create, successfully, proinsulin. The next steps will be to cut and fold proinsulin to make insulin.
“Most immediately, we’re aiming to set a milestone in what can be done by biohackers in a modestly funded and equipped lab, and inspire others to take on more ambitious projects and share the knowledge we develop along the way about doing so. I hope in the long run this empowers people working in small-scale settings to not just duplicate what can already be done in big labs and factories, but to actually innovate,” said the project mentor.
Adapted from: https://bit.ly/2KivcXB
More info: http://openinsulin.org
This solution shall not include mention to the use of drugs, chemicals or biologicals (including food); invasive devices; offensive, commercial or inherently dangerous content. This solution was not medically validated. Proceed with caution! If you have any doubts, please consult with a health professional.
DISCLAIMER: This story was written by someone who is not the author of the solution, therefore please be advised that, although it was written with the utmost respect for the innovation and the innovator, there can be some incorrect statements. If you find any errors please contact the patient Innovation team via info@patient-innovation.com
-
-
444
-
0
-
12512
Nightscout – an open source, do-it-yourself continuous glucose monitor in the Cloud
Type 1 diabetes mellitus
Diabetes insipidus
Diabetes mellitus
Diabetes mellitus (incl subtypes)
Diabetes mellitus inadequate control
Fulminant type 1 diabetes mellitus
Cystic fibrosis related diabetes
Gestational diabetes
Insulin-requiring type 2 diabetes mellitus
Latent autoimmune diabetes in adults
Diabetes with hyperosmolarity
Diabetes complicating pregnancy
Insulin resistant diabetes
Type 2 diabetes mellitus
Type 3 diabetes mellitus
Pancreatogenous diabetes
Glucose metabolism disorders (incl diabetes mellitus)
Nephrogenic diabetes insipidus
Acquired lipoatrophic diabetes
Congenital central diabetes insipidus
Hyperglycaemia
Carbohydrate metabolism disorder
Inborn errors of carbohydrate metabolism (excl glucose)
Pancreas
Mobile app
Software
Insulin injector
Insulin pen
Insulin injection
Diabetes mellitus management
-
-
-
301
-
1
-
11018
Girl creates low-cost home dialysis machine
Diabetes insipidus
Diabetes mellitus
Diabetes mellitus (incl subtypes)
Glomerulonephritis
Kidney enlargement
Glomerulonephritis acute
Glomerulonephritis chronic
Chronic renal failure
chronic kidney failure
Kidney
electronic device
Haemodialyzer
Urination
Oedema peripheral
Localised oedema
Oliguria
Anuria
Dialysis
Dialysis device insertion
Haemodialysis
Peritoneal dialysis
-
-
-
364
-
12
-
10106
Diabetic invents app to manage diabetes
Diabetes mellitus (incl subtypes)
Diabetes mellitus inadequate control
Acquired lipoatrophic diabetes
Diabetes mellitus
Diabetes with hyperosmolarity
Congenital central diabetes insipidus
Diabetes complicating pregnancy
Diabetes mellitus malnutrition-related
Diabetes insipidus
Cystic fibrosis related diabetes
Insulin-requiring type 2 diabetes mellitus
Type 1 diabetes mellitus
Congenital nephrogenic diabetes insipidus
Insulin resistant diabetes
Fulminant type 1 diabetes mellitus
Gestational diabetes
Latent autoimmune diabetes in adults
Type 2 diabetes mellitus
Type 3 diabetes mellitus
Pancreatogenous diabetes
Nephrogenic diabetes insipidus
Mobile app
-